Seong-Jin Park

This study identifies TOX as a critical regulator of tumor-infiltrating regulatory T cells, showing its role in maintaining immunosuppression and its potential as a therapeutic target.

This paper develops DPARC, a zero-shot insulin delivery system using reinforcement learning to adapt to physiological changes without prior personalization, showing improved glucose control in simulations and pigs.